ArticleFrontiers in pharmacology2024

A real-world disproportionality analysis of mesalazine data mining of the public version of FDA adverse event reporting system.

Mingdi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.